Universe Pharmaceuticals Inc Financial Flexibility Index
Universe Pharmaceuticals Inc financial flexibility index. Universe Pharmaceuticals Inc (UPC) has a Financial Flexibility Index of -0.57x as of December 2025. Free cash flow of $-7.44 Million (operating CF $-7.61 Million minus capex $169.99K) represents -1% of total liabilities ($13.17 Million). See UPC cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Universe Pharmaceuticals Inc (2018–2025)
Financial flexibility index of Universe Pharmaceuticals Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Universe Pharmaceuticals Inc across 8 annual periods. Check Universe Pharmaceuticals Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Universe Pharmaceuticals Inc Financial Flexibility Index by Year (2018–2025)
Universe Pharmaceuticals Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Universe Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Universe Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.36x | $-4.71 Million | $-5.05 Million | $13.17 Million | ▲ +12.3% |
| 2024 | -0.41x | $-9.14 Million | $-9.51 Million | $22.45 Million | ▼ -581.2% |
| 2023 | 0.08x | $1.16 Million | $1.12 Million | $13.75 Million | ▲ +191.0% |
| 2022 | -0.09x | $-1.22 Million | $-1.31 Million | $13.10 Million | ▼ -109.1% |
| 2021 | 1.02x | $11.48 Million | $-2.06 Million | $11.21 Million | ▲ +32.8% |
| 2020 | 0.77x | $6.17 Million | $6.12 Million | $8.00 Million | ▼ -68.4% |
| 2019 | 2.44x | $13.29 Million | $13.20 Million | $5.45 Million | ▲ +874.6% |
| 2018 | 0.25x | $4.60 Million | $4.46 Million | $18.40 Million | — |